COMMUNIQUÉ DE PRESSE publié le 24/01/2024 à 14:00, il y a 10 mois 28 jours AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:00, il y a 1 année 2 mois AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 23/08/2023 à 14:00, il y a 1 année 3 mois AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
COMMUNIQUÉ DE PRESSE publié le 06/07/2023 à 14:00, il y a 1 année 5 mois AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 04/04/2023 à 14:00, il y a 1 année 8 mois AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Publié le 21/12/2024 à 12:17, il y a 2 heures 2 minutes AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Publié le 21/12/2024 à 12:17, il y a 2 heures 2 minutes AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Publié le 20/12/2024 à 18:00, il y a 20 heures 19 minutes Kapitaalverhoging door uitoefening van inschrijvingsrechten
Publié le 20/12/2024 à 18:00, il y a 20 heures 19 minutes Capital increase through exercise of subscription rights
Publié le 20/12/2024 à 17:55, il y a 20 heures 24 minutes Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024
Publié le 21/12/2024 à 01:30, il y a 12 heures 49 minutes Quantum Biopharma Announces Closing of Second Tranche
Publié le 21/12/2024 à 01:30, il y a 12 heures 49 minutes iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Publié le 21/12/2024 à 00:05, il y a 14 heures 14 minutes Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Publié le 20/12/2024 à 23:30, il y a 14 heures 49 minutes Boron One Announces Extension to Early Warrant Exercise Incentive Program
Publié le 21/12/2024 à 00:51, il y a 13 heures 28 minutes Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Publié le 21/12/2024 à 00:45, il y a 13 heures 34 minutes EQS-Adhoc: PSI sells the Mobility business unit
Publié le 20/12/2024 à 19:10, il y a 19 heures 9 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 20/12/2024 à 18:56, il y a 19 heures 23 minutes CPI PROPERTY GROUP – Progress on Key Initiatives
Publié le 20/12/2024 à 18:00, il y a 20 heures 19 minutes ARYZTA AG Announces New Board Technology Committee
